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The release of Ca*+ from rat liver mitochondria induced by t-butylhydroperoxide m tabolism iscaused 
by pyridine nucleotide oxidation and precedes alterations inmembrane permeability which appear to result 
from, rather than cause, Ca*+ release. 
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1. INTRODUCTION 
The multiple effects of several hormones are 
now known to be mediated by alterations of in- 
tracellular Ca2+ homeostasis (see [ 11). Various tox- 
ic agents, including t-butylhydroperoxide (tBH) 
have been found to cause perturbation of in- 
tracellular Ca2+ compartmentation in isolated 
hepatocytes prior to other indications of toxicity 
[2]. The metabolism of tBH by the glutathione 
peroxidase-glutathione reductase system results in 
the oxidation of glutathione and NAD(P)H. 
Simultaneously, Ca2+ is depleted from the 
mitochondrial and endoplasmic reticular compart- 
ments by pyridine nucleotide- and thiol-dependent 
processes [3]. The mechanisms controlling in- 
tracellular Ca’+ homeostasis, and the conse- 
quences of its alterations, are thus of both 
physiological and toxicological interest. 
ed to involve a Ca*+/2 H+ antiport carrier 
regulated by the intramitochondrial pyridine 
nucleotide redox state [6]. Several studies with tBH 
have correlated NAD(P)H oxidation and Ca*+ 
release [7,8] supporting this idea. However, others 
have proposed a less specific release mechanism in- 
volving the stimulated formation of free fatty acids 
and lysophospholipids by phospholipase A2 [9, lo]. 
This would result in a non-specific membrane 
permeability increase, swelling, loss of transmem- 
brane potential and Ca*+ release, which would oc- 
cur independently of NAD(P)H oxidation. 
The mitochondria sequester a large portion of 
the cellular Ca2+ and play a major role in the 
regulation of the Ca*+ concentration in the cytosol 
[4]. Ca*+ cycling in liver mitochondria occurs by 
two distinct transport routes (see [5]), an elec- 
trogenic, ruthenium red-sensitive uptake carrier 
and an electroneutral efflux pathway which is not 
yet well characterized. The latter has been propos- 
The aim of this study was to determine the 
relative importance of NAD(P)H oxidation and 
membrane permeability changes during tBH- 
induced Ca*+ release by liver mitochondria. Under 
our conditions the pyridine nucleotide redox state 
and Ca*+ fluxes are closely linked. Permeability 
changes can be dissociated from these events and 
seem to result from, rather than cause, Ca*+ 
release. 
2. MATERIALS AND METHODS 
* To whom correspondence should be addressed 
+ Present address: Clinica Medica II=, University of 
Pavia, Pavia, Italy 
Rat liver mitochondria were isolated from male 
Sprague-Dawley rats (200-280 g) as in [l 11. Pro- 
tein was determined by the Lowry assay [ 121. 
The standard incubation mixture (1 ml) contain- 
ed 1 mg mitochondrial protein, 210 mM mannitol, 
70 mM sucrose, 5 mM succinate, 3 PM rotenone, 
0.15% bovine serum albumin (BSA), free fatty 
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acid, 10 mM Tris-HCl (pH 7.4) and (for Ca2+ 
measurements only) 60 GM arsenazo III. All 
measurements were conducted at 25°C. Where in- 
dicated, incubations were performed in this 
medium without BSA. 
Measurements of mitochondrial calcium fluxes, 
swelling and pyridine nucleotide oxidation state 
were performed spectrophotometrically at 
654-685 nm, 540 nm and 340-370 nm, respective- 
ly. To correlate these events, Ca2+ fluxes and swell- 
ing or NAD(P)H changes were measured 
simultaneously with two spectrophotometers 
(Aminco DW-2 and Sigma ZWS-II). Additions to 
the incubations were made as indicated in the 
legends to figures. All concentrations given are 
final concentrations. 
Chemicals were obtained commercially and were 
of analytical reagent grade, except ruthenium red 
(45% pure), which was used without further 
purification. 
3. RESULTS AND DISCUSSION 
Bovine serum albumin (0. l-l .O%) is routinely 
used in mitochondrial incubations to bind free fat- 
ty acids and lysophospholipids and to prevent non- 
specific membrane effects [13,14]. Fatty acids are 
known to disrupt mitochondrial functions by in- 
terfering with substrate transporters, increasing 
membrane permeability and uncoupling respira- 
tion [13]. Fig. 1 shows a comparison of the effects 
of tBH on Ca2+ release by mitochondria incubated 
in the presence or absence of BSA. In both cases 
the pattern of Ca2+ release was dependent on the 
concentration of tBH. In the presence of BSA the 
mitochondria could maintain high Ca2+ loads 
(I 100 nmol/mg protein) for at least 15 min and 
released Ca2+ steadily when exposed to fairly high 
concentrations of tBH. When BSA was not pre- 
sent, the mitochondria were far more sensitive to 
both Ca2+ and tBH. Ca2+ could be taken up but 
was released spontaneously within several minutes. 
Additionof very low amounts of tBH (I 10 PM) 
caused a partial release of Ca2+ which was follow- 
ed by reuptake. At higher tBH concentrations very 
rapid and complete Ca2+ release was induced. In 
both incubation systems an increased sensitization 
towards tBH was observed as the Ca2+ load was in- 
creased (not shown) in agreement with [8]. 
To determine the chronological order of events 
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Fig. 1. Mitochondrial Ca2+ release induced by tBH in the 
presence and absence of 0.15% BSA. Mitochondria were 
preloaded with 70 nmol Ca’+/mg protein: (- - -) 
control traces, for which no further additions were 
made; (-) tBH was added (-+) at the FM levels 
shown. 
associated with tBH-induced Ca” release, 
simultaneous measurements of Ca2+ release, 
NAD(P)H oxidation and mitochondrial swelling 
were performed. Results from incubations in the 
presence of BSA are shown in fig.2. The sequence 
occurred as follows: NAD(P)H oxidation, Ca2+ 
release, swelling. Complete NAD(P)H oxidation 
occurred within 4 min after tBH addition. Swelling 
began after 15% of the total Ca2+ had been releas- 
ed and did not reach a maximum rate until release 
was 80% complete, indicating that it is not 
permeability changes which initiate Ca2+ efflux. In 
the absence of BSA, the commencement of these 
events occurred too rapidly for determination of 
their sequence (not shown). 
Several ines of evidence indicate that mitochon- 
drial Ca2+ release induced by tBH is linked to the 
metabolism of the hydroperoxide. We had shown 
Volume 153, number 2 FEBS LETTERS March 1983 
Ca2+ release 
1 
15 nmol 
Swehng 
I 
Ab+jl(y 0.05 
b 
C 
d 
NAD(P)H oxldatlon I,nmo, -+A& 
10 
Fig.2. Sequence and reversibility of tBH-induced Ca2+ 
release, mitochondrial swelling and NAD(P)H 
oxidation. Mitochondria were preloaded with 105 nmol 
Ca2+/mg protein in an incubation medium containing 
BSA: (---) control traces, for which no further 
additions were made; (-) tBH (3 mM) was added 
where indicated by the large arrow. Subsequent 
additions (at small arrows) were as follows: (a) none; (b) 
0.5 mM isocitrate; (c) 1 mM isocitrate; (d) 2 mM 
isocitrate. 
this by diethylmaleate pretreatment of the rats, 
which prevents both tBH metabolism (by depletion 
of GSH required for glutathione peroxidase activi- 
ty) and Ca’+ release [111. Similar results have been 
obtained when glutathione peroxidase activity has 
been reduced by keeping rats on a selenium- 
deficient diet [7]. Further evidence that t,BH- 
induced effects are metabolically linked is shown 
in fig.2. Addition of the NAD(P)+-reducing agents 
isocitrate or P-hydroxybutyrate caused complete 
Ca2+ reuptake if added before 75% of total Ca2+ 
had been released. Beyond this point reversibility 
was poor. Both the extent of reuptake and dura- 
tion of retention were dependent upon the amount 
of reducing agent added, indicative of a 
metabolically dependent process. Pyridine 
nucleotides were reduced to 40% of their original 
value during Ca2+ reuptake. When Ca2+ reuptake 
could not be induced, little NAD(P)+ reduction 
was observed. This loss of reversibility may be 
associated with Ca2+-dependent hydrolysis of 
NAD(P)+ as in [8]. In contrast, mitochondrial 
swelling was permanently inhibited by these agents 
regardless of the state of reversibility. 
Results very similar to those observed with 
isocitrate could be obtained with the thiol reduc- 
tant dithiothreitol (DTT) (not shown). This com- 
pound causes non-enzymatic regeneration of 
reduced glutathione, independent of glutathione 
reductase and NADPH consumption. With DTT, 
Ca2+ release induced by tBH could be reversed in 
a dose-dependent manner, which was accompanied 
by decrease of NADPH oxidation and a lasting in- 
hibition of swelling. Once the restorative effects of 
isocitrate or DTT had been exhausted, release of 
Ca2+ occurred at the same rate and to the same ex- 
tent as in the absence of these agents (fig.2). Dur- 
ing re-release, no occurrence of swelling or 
NAD(P)H oxidation was observed. However, in 
the latter case, hydrolysis of NAD(P)+ may have 
decreased pyridine nucleotides to below 
detectability. 
Further experiments were performed to compare 
tBH-induced mitochondrial swelling and Ca2+ 
release. Under appropriate conditions, these two 
events could be completely dissociated (fig.3). The 
addition of ruthenium red together with tBH caus- 
ed a more rapid (although slightly less extensive) 
release of Ca2+ than with tBH alone, yet swelling 
was virtually eliminated by the presence of 
ruthenium red. Swelling was also prevented by the 
inclusion of EGTA in the medium during Ca2+ 
release. These observations, together with the se- 
quence and reversibility patterns in fig.2, strongly 
suggest hat the mitochondria are intact during all 
but the last stages of Ca2+ release, and that swell- 
ing is a consequence of this release. This agrees 
with results obtained from measurements of 
mitochondrial membrane potential during tBH 
metabolism in the presence and absence of EGTA 
[15]. Our results with ruthenium red indicate that 
the binding of released Ca2+ to the uniport carrier 
may be a key event in initiating swelling. This had 
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Fig.3. Dissociation of tBH-induced Ca2+ release from 
mitochondrial swelling. Mitochondria were preloaded 
with 65 nmol Ca’+/mg protein in the presence of BSA: 
(- --) control traces recorded without further 
additions; (-) additions were made (at large arrow) 
as follows: (a) 0.6 nmol ruthenium red; (b) 3 mM tBH; 
(c) 0.6 nmol ruthenium red plus 3 mM tBH; (d) 0.1 mM 
EGTA plus 3 mM tBH. Ca’+ fluxes cannot be measured 
by our method in the presence of EGTA. 
been suggested in studies on the Ca*+-induced 
membrane transition of beef heart mitochondria 
[161. 
Our results support the idea that tBH-induced 
Ca*+ release is not due to an increase in membrane 
permeability, but to a specific efflux process which 
is sensitive to the NAD(P)H and thiol redox states. 
These results are also in agreement with results ob- 
tained from studies of tBH toxicity in intact 
hepatocytes [3]. 
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